Solarvest BioEnergy Inc. (SVS.V) Research

Solarvest BioEnergy Inc. specializes in harnessing algal-based production systems to develop natural, environmentally friendly commercial products for both Canadian and international markets. The company's offerings span human nutrition, including omega-3; a clean energy solution for continuous hydrogen production; and pharmaceutical components for human health. These pharmaceutical applications specifically include cannabinoids derived from algae and bone morphogenetic protein for treating bone fractures. Solarvest BioEnergy Inc. also has a collaborative research and development agreement with FSD Pharma Inc. to create pharmaceutical-grade cannabinoids using algae. Established in 2005, the company is headquartered in Vancouver, Canada.

Market snapshot

Symbol
SVS.V
Price
$0.02
Day change
-20.00%
Market cap
$1.2M
P/E ratio
-0.68x
52-week range
0.01-0.14
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Braxia Scientific Corp. (BRAX.CN)
  • HAVN Life Sciences Inc. (HAVN.CN)
  • Enlighta Inc. (NLTA.V)
  • PsyBio Therapeutics Corp. (PSYB.V)
  • Pure Extracts Technologies Corp. (PULL.CN)
  • The Hash Corporation (REZN.CN)
  • RepliCel Life Sciences Inc. (RP.V)
  • TransCanna Holdings Inc. (TCAN.CN)

Open Solarvest BioEnergy Inc. (SVS.V) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.